Our Approach
Our Team And How We Work
Our Team And How We Work
Our Team And How We Work
The FIrstMileBio team delivers commercial strategy for your development programs and is comprised of industry experts in critical areas, including product development, market access and reimbursement, customer insights, commercial analytics, competitive intelligence, and commercialization strategy.
FirstMileBio offers early stage biotech
The FIrstMileBio team delivers commercial strategy for your development programs and is comprised of industry experts in critical areas, including product development, market access and reimbursement, customer insights, commercial analytics, competitive intelligence, and commercialization strategy.
FirstMileBio offers early stage biotech and venture capital companies a way to engage a highly experienced team with diverse functional background on a fractional and highly flexible basis as the needs of the company and drug candidates shift over time.
Our history
Our Team And How We Work
Our Team And How We Work
As a team, we have worked for many of the top biotech and pharmaceutical companies around the globe. As we engage with earlier stage companies, we realize that all seek to maximize the value of their assets and increasingly decide to commercialize without the help of a partner (at least in the US).
Yet, chances of commercial success are
As a team, we have worked for many of the top biotech and pharmaceutical companies around the globe. As we engage with earlier stage companies, we realize that all seek to maximize the value of their assets and increasingly decide to commercialize without the help of a partner (at least in the US).
Yet, chances of commercial success are slim: even after clearing the monumental hurdle of FDA approval, financial success remains elusive. Research on over 2,000 Phase I compounds shows that fewer than 15% are ever approved and of those, fewer than half launched by a first-time commercializing biotech deliver a positive ROI.
Launch success depends on early expert understanding of a complex customer ecosystem—physicians, patients, payers, regulators, and others — each with unique needs that must be reflected in the target product profile (TPP).
Early commercial insights are required to identify and translate those needs into product requirements that align clinical, regulatory, manufacturing and medical efforts before critical TPP decisions are locked in. Since formulation, target indication, and endpoints are often set before Phase I, it is vital to invest in market insights before the product enters the clinic.
That's where FirstMileBio comes in:
It provides an integrated team of experienced, fractional executives – with a mandate to generate market insights, help define a marketable, differentiated product profile (TPP), work cross-functionally to align development efforts, and articulate the compelling go-to-market strategy for the Board of Directors and investors – all of which evolve as the business learns and grows.
